Status:
UNKNOWN
Effectiveness and Adoption of the TelTex4BP Intervention Among Adults With Hypertension in Nepal
Lead Sponsor:
Central Department of Public Health
Collaborating Sponsors:
Harvard School of Public Health (HSPH)
Conditions:
Hypertension
Medication Adherence
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Despite evidence of preventing cardiovascular disease (CVD) risk through lifestyle changes, many patients with hypertension (HTN) do not comply with this and suffer from CVD and other complications. A...
Detailed Description
This study will be a hybrid type 2 effectiveness-implementation study using mixed methods, a parallel randomized controlled trial with a nested qualitative design. The intervention will be codesigned ...
Eligibility Criteria
Inclusion
- Clinical diagnosis of hypertension
- Currently receiving/prescribed blood pressure-lowering medication for more than three month
- With uncontrolled blood pressure (\>140/90mm of Hg)
- Should have access to a mobile phone
- Able to read text messages ( by themselves/with the help of family)
Exclusion
- Diagnosed with myocardial infarction, stroke, and kidney failure
- Severe mental illness, cognitive impairment
- Pregnant women or in the postpartum period
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05979168
Start Date
August 1 2023
End Date
August 1 2025
Last Update
August 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Central Department of Public Health
Kathmandu, Pradesh 3 (Bagmati), Nepal, 40660